The anti-inflammatory effect of compound 36 observed in rats with CIA in the present study seemed to be, at least partially, related to its TNF-α-inhibitory activity because TNF-α is a crucial mediator responsible for the progression of RA in humans and is also associated with the pathogenesis of CIA in rats [35]. Here, TNF is linked to rheumatoid arthritis.